Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

Université de Montréal

$17,500.00

Unprecedented role for the novel lactate receptor GPR81 in protecting against choroidal involution as seen in age-related macular degeneration

FY 2018-19

Summary
Age-related macular degeneration (AMD) is the leading cause of blindness in industrialized countries, imposing massive burden on individuals and the society. To this day, available therapeutic interventions fail to completely treat this condition. This is in a big part because of our primitive understanding from the basic pathology of this disease. Briefly, AMD is defined in two clinical forms: “the dry form” and “the wet form”. Although each of these forms have their special characteristics, both ultimately converge toward the detachment of retina. Accumulative evidences show AMD starts with damage to the blood supplying tissue of retina, Choroid. Inflammation occurring between the retina and the choroid frequently causes irreversible damage. High level of Lactate is produced in retina as the results of oxygen supply loss because of the damage to choroid. Although properties of this metabolite is ill-defined so far; recently a lactate-binding receptor, named “GPR81” has been discovered. GPR81 is indicated to have angiogenic and anti-inflammatory effects which are of interest to AMD. Thus, GPR81 could be a relevant target for AMD. This project will study the underlying mechanism of GPR81 in AMD pathogenesis and would explore possible therapeutic value of GPR81 for AMD.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406637
Name
Prairie Élizabeth
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Unprecedented role for the novel lactate receptor GPR81 in protecting against choroidal involution as seen in age-related macular degeneration
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Age-Related Macular Degeretation; Choroidal Thinning; Chronic Hypoxia; Degeneration Of Photoreceptors; Gpr81; Lactate; Neovascularization; Oxidant Stress; Retina; Retinal Pigment Epithelium
Abstract
Age-related macular degeneration (AMD) is the leading cause of blindness in industrialized countries, imposing massive burden on individuals and the society. To this day, available therapeutic interventions fail to completely treat this condition. This is in a big part because of our primitive understanding from the basic pathology of this disease. Briefly, AMD is defined in two clinical forms: “the dry form” and “the wet form”. Although each of these forms have their special characteristics, both ultimately converge toward the detachment of retina. Accumulative evidences show AMD starts with damage to the blood supplying tissue of retina, Choroid. Inflammation occurring between the retina and the choroid frequently causes irreversible damage. High level of Lactate is produced in retina as the results of oxygen supply loss because of the damage to choroid. Although properties of this metabolite is ill-defined so far; recently a lactate-binding receptor, named “GPR81” has been discovered. GPR81 is indicated to have angiogenic and anti-inflammatory effects which are of interest to AMD. Thus, GPR81 could be a relevant target for AMD. This project will study the underlying mechanism of GPR81 in AMD pathogenesis and would explore possible therapeutic value of GPR81 for AMD.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Prairie, Élizabeth
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~